TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program March 11, 1994
TCL Archive NCI Seen Shifting Away From Comprehensive Center Emphasis Toward Encouraging Clinical Excellence April 30, 1976